How 25 years of psychosocial research has contributed to a better understanding of the links between depression and diabetes.
François PouwerM T SchramM M IversenArie NouwenR I G HoltPublished in: Diabetic medicine : a journal of the British Diabetic Association (2020)
This narrative review of the literature provides a summary and discussion of 25 years of research into the complex links between depression and diabetes. Systematic reviews have shown that depression occurs more frequently in people with type 1 or type 2 diabetes compared with people without diabetes. Currently, it remains unclear whether depression is also more common in people with impaired glucose metabolism or undiagnosed type 2 diabetes compared with people without diabetes. More prospective epidemiological research into the course of depression and an exploration of mechanisms in individuals with diabetes are needed. Depression in diabetes is associated with less optimal self-care behaviours, suboptimal glycaemic control, impaired quality of life, incident micro- and macrovascular diseases, and elevated mortality rates. Randomized controlled trails concluded that depression in diabetes can be treated with antidepressant medication, cognitive-behavioural therapy (individual, group-based or web-based), mindfulness-based cognitive therapy and stepped care. Although big strides forward have been made in the past 25 years, scientific evidence about depression in diabetes remains incomplete. Future studies should investigate mechanisms that link both conditions and test new diabetes-specific web- or app-based interventions for depression in diabetes. It is important to determine whether treatment or prevention of depression prevents future diabetes complications and lowers mortality rates.
Keyphrases
- type diabetes
- glycemic control
- cardiovascular disease
- depressive symptoms
- sleep quality
- systematic review
- insulin resistance
- risk factors
- major depressive disorder
- open label
- machine learning
- cardiovascular events
- stem cells
- coronary artery disease
- mental health
- metabolic syndrome
- emergency department
- weight loss
- bipolar disorder
- randomized controlled trial
- cell therapy
- combination therapy
- placebo controlled
- chronic pain
- skeletal muscle
- quality improvement
- pain management